5/14
10:41 am
wat
Biopharmaceutical Process Analytical Technology Market Worth $2.6 billion | MarketsandMarkets™ [Yahoo! Finance]
Low
Report
Biopharmaceutical Process Analytical Technology Market Worth $2.6 billion | MarketsandMarkets™ [Yahoo! Finance]
5/13
02:00 pm
wat
Waters Corporation to Present at the Jefferies 2024 Healthcare Conference
Low
Report
Waters Corporation to Present at the Jefferies 2024 Healthcare Conference
5/13
12:49 pm
wat
Waters (WAT) International Revenue in Focus: Trends and Expectations [Yahoo! Finance]
Low
Report
Waters (WAT) International Revenue in Focus: Trends and Expectations [Yahoo! Finance]
5/13
09:00 am
wat
ObeEnd - Pioneering Drug-Free Weight Management Wristband
Low
Report
ObeEnd - Pioneering Drug-Free Weight Management Wristband
5/9
10:50 am
wat
Estimating The Fair Value Of Waters Corporation (NYSE:WAT) [Yahoo! Finance]
Low
Report
Estimating The Fair Value Of Waters Corporation (NYSE:WAT) [Yahoo! Finance]
5/8
04:12 pm
wat
Is your company moving too slow, or too fast, on gen AI? [Yahoo! Finance]
Medium
Report
Is your company moving too slow, or too fast, on gen AI? [Yahoo! Finance]
5/8
04:01 pm
wat
Waters Corporation (NYSE:WAT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Waters Corporation (NYSE:WAT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/8
03:33 pm
wat
Waters Co. (NYSE: WAT) had its price target lowered by analysts at Barclays PLC from $300.00 to $295.00. They now have an "underweight" rating on the stock.
Low
Report
Waters Co. (NYSE: WAT) had its price target lowered by analysts at Barclays PLC from $300.00 to $295.00. They now have an "underweight" rating on the stock.
5/8
02:05 pm
wat
Is your company moving too slow, or too fast, on gen AI? [Fortune]
Low
Report
Is your company moving too slow, or too fast, on gen AI? [Fortune]
5/8
01:45 pm
wat
Waters Co. (NYSE: WAT) had its price target raised by analysts at TD Cowen from $350.00 to $358.00. They now have a "hold" rating on the stock.
Low
Report
Waters Co. (NYSE: WAT) had its price target raised by analysts at TD Cowen from $350.00 to $358.00. They now have a "hold" rating on the stock.
5/8
10:09 am
wat
Waters Co. (NYSE: WAT) had its price target raised by analysts at Stifel Nicolaus from $330.00 to $332.00. They now have a "hold" rating on the stock.
Low
Report
Waters Co. (NYSE: WAT) had its price target raised by analysts at Stifel Nicolaus from $330.00 to $332.00. They now have a "hold" rating on the stock.
5/8
08:52 am
wat
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument [Yahoo! Finance]
Low
Report
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument [Yahoo! Finance]
5/8
08:40 am
wat
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument
Low
Report
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument
5/8
08:14 am
wat
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument
Low
Report
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument
5/8
08:07 am
wat
Waters Co. (NYSE: WAT) had its price target lowered by analysts at Robert W. Baird from $319.00 to $312.00. They now have a "neutral" rating on the stock.
Low
Report
Waters Co. (NYSE: WAT) had its price target lowered by analysts at Robert W. Baird from $319.00 to $312.00. They now have a "neutral" rating on the stock.
5/8
08:00 am
wat
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument
Low
Report
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument
5/7
11:13 am
wat
Compared to Estimates, Waters (WAT) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]
Neutral
Report
Compared to Estimates, Waters (WAT) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]
5/7
06:50 am
wat
Waters Corporation (NYSE: WAT) Reports First Quarter 2024 Financial Results
Low
Report
Waters Corporation (NYSE: WAT) Reports First Quarter 2024 Financial Results
5/6
12:48 pm
wat
Waters (WAT) to Report Q1 Earnings: What's in the Offing? [Yahoo! Finance]
Low
Report
Waters (WAT) to Report Q1 Earnings: What's in the Offing? [Yahoo! Finance]
5/2
10:45 am
wat
Unlocking Q1 Potential of Waters (WAT): Exploring Wall Street Estimates for Key Metrics [Yahoo! Finance]
Low
Report
Unlocking Q1 Potential of Waters (WAT): Exploring Wall Street Estimates for Key Metrics [Yahoo! Finance]
4/30
12:11 pm
wat
Earnings Preview: Waters (WAT) Q1 Earnings Expected to Decline [Yahoo! Finance]
Low
Report
Earnings Preview: Waters (WAT) Q1 Earnings Expected to Decline [Yahoo! Finance]
4/23
03:55 am
wat
Global Chromatography Software Market Analysis & Forecast 2024-2034, Featuring Bruker, Waters, Restek, Gilson, Shimadzu, Cytiva, Scion Instruments, DataApex, KNAUER and Agilent Technologies [Yahoo! Finance]
Medium
Report
Global Chromatography Software Market Analysis & Forecast 2024-2034, Featuring Bruker, Waters, Restek, Gilson, Shimadzu, Cytiva, Scion Instruments, DataApex, KNAUER and Agilent Technologies [Yahoo! Finance]
4/22
08:13 am
wat
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns [Yahoo! Finance]
Low
Report
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns [Yahoo! Finance]
4/22
08:13 am
wat
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns [Yahoo! Finance]
Low
Report
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns [Yahoo! Finance]
4/22
08:00 am
wat
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns
Low
Report
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns